Is AI in healthcare hype or real? – Delta: HealthTech Innovators
Roupen Odabashian shared a post by Delta: HealthTech Innovators on LinkedIn, adding the following:
“I remember in 2020-2021 when telemedicine was everywhere.
I thought that after that year, I would be able to do virtual clinics for the rest of my life, but that wasn’t the case.
However, I have more optimism when it comes to AI in healthcare.
Check out this episode on Delta: HealthTech Innovators.” .
Quoting Delta: HealthTech Innovators’ post:
“Is AI in healthcare hype or real?
In 2020, it was the dot-com boom. During COVID, it was the telemedicine boom, and now it’s AI. Where does AI stand in healthcare? What does the appetite for AI look like in 2024?
These and many other topics were covered in this amazing episode with Aaron DeGagne, CFA, a financial analyst from PitchBook with deep knowledge in the healthcare industry.
For the full episode, check:
Source: Roupen Odabashian/LinkedIn and Delta: HealthTech Innovators/LinkedIn
Dr. Roupen Odabashian is an accomplished Internal Medicine Physician and Hematology/Oncology Fellow with a profound commitment to advancing healthcare through clinical practice, research, and technology.
Currently based at the prestigious Karmanos Cancer Institute, Dr. Odabashian is actively involved in pioneering cancer treatments and conducting clinical research.
In addition to his clinical work, Dr. Odabashian is a multifaceted healthcare professional. He hosts podcast at OncoDaily, engaging with leading experts in oncology to share valuable insights with the medical community.
Dr. Odabashian also contributes his expertise as an advisor at Spiraldot Health and Mesh AI, supporting innovative ventures in healthcare technology and collaborative scheduling to combat clinician burnout.
With his diverse roles and unwavering dedication, Dr. Odabashian exemplifies a commitment to driving positive change in healthcare.